{{chembox
| ImageFile = Aceglutamide.svg
| ImageFile_Ref = {{chemboximage|correct|??}}
| ImageSize = 160
| ImageName = Stereo, skeletal formula of aceglutamide (S)
| IUPACName = 2-(Acetylamino)-glutaramidic acid
| OtherNames = KW-110; α-''N''-Acetylglutamine;<ref name="Elks2014" /> aceglutamide aluminum ([[Japanese Accepted Name|JAN]], [[United States Adopted Name|USAN]]) 
|Section1={{Chembox Identifiers
| CASNo = 2490-97-3
| CASNo_Ref = {{cascite|correct|??}}
| CASNo_Comment = <small>''S''</small>
| PubChem = 25561
| PubChem1 = 444019
| PubChem1_Comment = <small>''R''</small>
| PubChem2 = 182230
| PubChem2_Comment = <small>''S''</small>
| ChemSpiderID = 23836
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}}
| ChemSpiderID1 = 392045
| ChemSpiderID1_Ref = {{chemspidercite|correct|chemspider}}
| ChemSpiderID1_Comment = <small>''R''</small>
| ChemSpiderID2 = 158492
| ChemSpiderID2_Ref = {{chemspidercite|correct|chemspider}}
| ChemSpiderID2_Comment = <small>''S''</small>
| UNII = 01J18G9G97
| UNII_Ref = {{fdacite|correct|FDA}}
| EINECS = 219-647-7
| DrugBank = DB04167
| DrugBank_Ref = {{drugbankcite|correct|drugbank}}
| KEGG = D07063
| KEGG_Ref = {{keggcite|correct|kegg}}
| MeSHName = aceglutamide
| SMILES = CC(=O)NC(CCC(N)=O)C(O)=O
| StdInChI = 1S/C7H12N2O4/c1-4(10)9-5(7(12)13)2-3-6(8)11/h5H,2-3H2,1H3,(H2,8,11)(H,9,10)(H,12,13)
| StdInChI_Ref = {{stdinchicite|correct|chemspider}}
| StdInChIKey = KSMRODHGGIIXDV-UHFFFAOYSA-N
| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}}
}}
|Section2={{Chembox Properties
| C=7 | H=12 | N=2 | O=4 
| Appearance = White crystals
| MeltingPtC = 197
}}
|Section3={{Chembox Related
| OtherFunction_label = alkanoic acids
| OtherFunction = {{unbulleted list|[[n-Acetylaspartic acid|''N''-Acetylaspartic acid]]|[[n-Acetylglutamic acid|''N''-Acetylglutamic acid]]|[[Citrulline]]|[[Pivagabine]]}}
| OtherCompounds = {{unbulleted list|[[Bromisoval]]|[[Carbromal]]}}
}}
}}

'''Aceglutamide''' (brand name '''Neuramina'''), or '''aceglutamide aluminum''' (brand name '''Glumal'''), also known as '''acetylglutamine''', is a [[psychostimulant]], [[nootropic]], and [[antiulcer agent]] that is marketed in [[Spain]] and [[Japan]].<ref name="Elks2014">{{cite book|author=J. Elks|title=The Dictionary of Drugs: Chemical Data: Chemical Data, Structures and Bibliographies|url=https://books.google.com/books?id=0vXTBwAAQBAJ&pg=PA3|date=14 November 2014|publisher=Springer|isbn=978-1-4757-2085-3|pages=3–}}</ref><ref>{{cite book|title=Index Nominum 2000: International Drug Directory|url=https://books.google.com/books?id=5GpcTQD_L2oC&pg=PA6|date=January 2000|publisher=Taylor & Francis|isbn=978-3-88763-075-1|pages=6–}}</ref><ref name="Publishing2013">{{cite book|author=William Andrew Publishing|title=Pharmaceutical Manufacturing Encyclopedia, 3rd Edition|url=https://books.google.com/books?id=_J2ti4EkYpkC&pg=PA35|date=22 October 2013|publisher=Elsevier|isbn=978-0-8155-1856-3|pages=35–}}</ref><ref name="MortonHall2012">{{cite book|author1=I.K. Morton|author2=Judith M. Hall|title=Concise Dictionary of Pharmacological Agents: Properties and Synonyms|url=https://books.google.com/books?id=tsjrCAAAQBAJ&pg=PA3|date=6 December 2012|publisher=Springer Science & Business Media|isbn=978-94-011-4439-1|pages=3–}}</ref> It is an [[acetyl]]ated form of the [[amino acid]] [[glutamine|<small>L</small>-glutamine]], the [[precursor (biochemistry)|precursor]] of [[glutamate]] in the body and [[brain]].<ref name="ZhangYang2015">{{cite journal|last1=Zhang|first1=Rui|last2=Yang|first2=Nan|last3=Ji|first3=Chao|last4=Zheng|first4=Ji|last5=Liang|first5=Zhen|last6=Hou|first6=Chun-Ying|last7=Liu|first7=Yan-Yong|last8=Zuo|first8=Ping-Ping|title=Neuroprotective effects of Aceglutamide on motor function in a rat model of cerebral ischemia and reperfusion|journal=Restorative Neurology and Neuroscience|volume=33|issue=5|year=2015|pages=741–759|issn=0922-6028|doi=10.3233/RNN-150509}}</ref> Aceglutamide functions as a [[prodrug]] to glutamine with improved [[potency (pharmacology)|potency]] and [[metabolic stability|stability]].<ref name="ZhangYang2015" /> Aceglutamide is used as a psychostimulant and nootropic, while aceglutamide aluminum is used in the treatment of ulcers.<ref>{{cite journal | pmid = 7095654 | year = 1982 | last1 = Ito | first1 = M | last2 = Yokochi | first2 = E | last3 = Kobayashi | first3 = C | last4 = Suzuki | first4 = Y | title = Studies on defensive factors of experimental ulcers (2). Increasing action of aceglutamide aluminum on defensive factors in acetic acid ulcers of rats (author's transl) | volume = 79 | issue = 4 | pages = 327–34 | journal = Nihon yakurigaku zasshi. Folia pharmacologica Japonica}}</ref><ref>{{cite journal | title = Inhibitory effect of N-acetyl-L-glutamine aluminum complex (KW-110) and related compounds on gastric erosion and motility in stressed animals |author1=Harada, Masatoshi |author2=Yano, Shingo | journal = Oyo Yakuri  | year = 1974 | volume = 8 | issue = 1 | pages = 1–6}}</ref><ref>{{cite journal | pmid = 1790087 | year = 1991 | last1 = Varas Lorenzo | first1 = MJ | last2 = López Martínez | first2 = A | last3 = Gordillo Bernal | first3 = J | last4 = Mundet Surroca | first4 = J | title = Comparative study of 3 drugs (aceglutamide aluminum, zinc acexamate, and magaldrate) in the long-term maintenance treatment (1 year) of peptic ulcer | volume = 80 | issue = 2 | pages = 91–4 | journal = Revista espanola de enfermedades digestivas : organo oficial de la Sociedad Espanola de Patologia Digestiva}}</ref><ref>{{cite journal | pmid = 7098147 | year = 1982 | last1 = Tanaka | first1 = H | last2 = Shuto | first2 = K | last3 = Marumo | first3 = H | title = Effect of N-acetyl-L-glutamine aluminum complex (KW-110), an antiulcer agent, on the non-steroidal anti-inflammatory drug-induced exacerbation of gastric ulcer in rats | volume = 32 | issue = 2 | pages = 307–13 | journal = Japanese journal of pharmacology | doi=10.1254/jjp.32.307}}</ref> Aceglutamide can also be used as a liquid-stable source of glutamine to prevent damage from protein energy malnutrition.<ref>{{cite journal |author1=Lopez-Pedrosa Jose M |author2=Manzano Manuel |author3=Baxter Jeffrey H |author4=Rueda Ricardo | journal = Digestive diseases and sciences  | year = 2007 | volume = 52 | issue = 3 | pages = 650–658 | doi = 10.1007/s10620-006-9500-y | pmid = 17253138 | title = N-acetyl-L-glutamine, a liquid-stable source of glutamine, partially prevents changes in body weight and on intestinal immunity induced by protein energy malnutrition in pigs}}</ref><ref>{{cite patent|JP|10101576}}</ref><ref>{{cite patent|US|2003099722}}</ref> The drug has shown [[neuroprotective]] effects in an [[animal model]] of [[cerebral ischemia]].<ref name="ZhangYang2015" />

==See also==
* [[Aceburic acid]]
* [[Aceturic acid]]
* [[N-Acetylglutamic acid]]

==References==
{{Reflist|2}}


{{Nootropics}}
{{Stimulants}}
{{Drugs for peptic ulcer and GORD}}
{{Antacids}}
{{Glutamatergics}}

[[Category:Acetamides]]
[[Category:Aluminium compounds]]
[[Category:Amino acid derivatives]]
[[Category:Drugs acting on the gastrointestinal system and metabolism]]
[[Category:Nootropics]]
[[Category:Prodrugs]]
[[Category:Stimulants]]


{{gastrointestinal-drug-stub}}
{{nervous-system-drug-stub}}